TKD Represents Lead Investors in Convertible Debt Offering

Tarter Krinsky & Drogin LLP represented the lead investors in a $3.15 million senior secured convertible debenture investment in Proectus Pharmaceuticals, Inc., a developer of pharmaceuticals and medical devices. The TKD attorneys representing the lead investors were corporate partner James G. Smith and corporate associate Arthur Zagorsky.